To prevent dominance by an acknowledged adversary, the National Security Commission on Emerging Biotechnology (NSCEB) calls for a two-track strategy that helps American companies innovate more quickly ...

Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S.

KalVista's sebetralstat nears FDA approval as a first-in-class oral treatment for hereditary angioedema. Read here for an ...

United Therapeutics is building the Silver Spring public parking facility under a development agreement with Montgomery ...

Amid a massive reorganization of the federal healthcare infrastructure that has prompted pushback from biotech and healthcare ...

According to Tempest, its options include a partnership or licensing deal, as well as a merger or an acquisition.

All three of the major indexes (^DJI, ^GSPC, ^IXIC) closed higher in what was a wild week of trading. Market Domination Overtime Anchor Julie Hyman and Markets and Data Editor Jared Blikre break down ...

The government is looking at models like IN-SPACe and the Bio-RIDE in the space and biotech sectors to involve private ...

BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

A new consortium aims to speed the pace of basic science discovery in AD and related diseases. A future AI assistant is to ...